Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus

Summary

The purpose of this two-part multiple ascending dose study is to evaluate the safety and tolerability of multiple doses of MHS552 in adults with type 1 diabetes mellitus. Participants will be treated for 4 or 12 weeks followed by an 8 week follow-up period

Timeline

Start

2023-09-01

Primary completion

2025-04-14

Completion

2025-04-14

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications